Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Increase in BRCA testing may not necessarily mean better diagnosis of women at risk, study suggests

More women are requesting BRCA gene testing associated with certain types of cancer thanks to increased interest in the procedure.

25 Mar 2017

Study finds steady increase in BRCA testing among low-risk women

Discovery of the BRCA genetic mutation in the mid-90s represented a breakthrough in breast and ovarian cancer prevention. About 5-10% of breast cancer cases and 10-18% of ovarian cancer cases can be attributed to two BRCA mutations.

23 Mar 2017

Researchers develop new method that uses gene editing to find cancer's weak spots

Genetic mutations that cause cancer also weaken cancer cells, creating an opportunity for researchers to develop drugs that will selectively kill them, while sparing normal cells.

20 Mar 2017

Studies question use of readmission rate as metric in surgeries for ovarian cancer patients

To reduce costs and improve quality of care, the Centers for Medicaid and Medicare Services has made reducing readmission rates a priority, yet research studies presented today at the Society of Gynecologic Oncology’s 2017 Annual Meeting for Women’s Cancer question the use of the metric in surgeries performed in patients with ovarian cancer.

13 Mar 2017

Researchers identify protein biomarker linked to prognosis in high-grade serous ovarian cancer

Ovarian cancer researchers have identified a protein biomarker expressed on the surface of tumour cells in high-grade serous ovarian cancer, the most common and lethal subtype of the disease.

7 Mar 2017

Clinical study seeks to examine new combination therapy for treating AML patients

A pair of drugs that may be a one-two punch needed to help combat acute myeloid leukemia (AML), an aggressive blood cancer that kills nearly three-fourths of patients within five years of diagnosis, is the focus of a new multi-center clinical trial that will enroll patients at three sites across the U.S.

7 Mar 2017

Michigan Medicine opens first clinic in the United States that focuses on prostate cancer risk

It's well known that women with certain hereditary genetic mutations, particularly BRCA1 and BRCA2, have an increased risk of breast cancer. But in recent years, researchers have discovered a link between some of those same genetic mutations - along with a handful of others - and aggressive prostate cancer.

3 Mar 2017

Blocking protein found on surface of ovarian cancer cells could prevent metastasis, research suggests

Blocking a protein found on the surface of ovarian cancer cells could prevent or reduce the spread of the disease to other organs, according to new research at the University of Illinois at Chicago.

3 Mar 2017

NR could potentially prevent chemotherapy-induced peripheral neuropathy in cancer patients

A new study in rats suggests that nicotinamide riboside (NR), a form of vitamin B3, may be useful for treating or preventing nerve pain (neuropathy) caused by chemotherapy drugs.

24 Feb 2017

Study: Hormonal maintenance therapy may improve survival in women with low-grade serous carcinoma

For women with a rare subtype of epithelial ovarian or peritoneum cancer, known as low-grade serous carcinoma, hormone maintenance therapy may significantly improve survival, according to a new study from researchers at The University of Texas MD Anderson Cancer Center.

22 Feb 2017

Early diagnosis does not necessarily result in longer life, study of cancer screenings shows

Physicians and patients like to believe that early detection of cancer extends life, and quality of life. If a cancer is present, you want to know early, right?

20 Feb 2017

UT Southwestern scientists unravel role of PARP enzymes in major cellular activities

A component of an enzyme family linked to DNA repair, stress responses, and cancer also plays a role in enhancing or inhibiting major cellular activities under physiological conditions, new research shows.

16 Feb 2017

Analyzing copies of genes may offer new therapeutic approaches for ovarian cancer

A team of 18 University of California San Diego School of Medicine and Moores Cancer Center researchers has developed a new tool to analyze an often overlooked aspect of cancer genetics -- an alteration that results in the loss or gain in a copy of a gene.

15 Feb 2017

Osmium-based compound seen to target cancer cells from inside

Researchers have witnessed - for the first time - cancer cells being targeted and destroyed from the inside, by an organo-metal compound discovered by the University of Warwick.

13 Feb 2017

Study finds link between removal of ovaries and increased risk of heart disease, cancer and mortality

A study led by the University of Warwick has found a link between the removal of ovaries during hysterectomy and an increase in heart disease, cancer and premature death.

6 Feb 2017

Yale researchers identify new genetic defect in brain tumor cells that prevents DNA repair

In a new study, Yale Cancer Center researchers identified a novel genetic defect that prevents brain tumor cells from repairing damaged DNA.

3 Feb 2017

Defects in key gene spur breast and ovarian cancer growth, study shows

Defects in a key gene - long thought to drive cancer by turning off the protection afforded by the well-known BRCA genes - spur cancer growth on their own, according to a study led by researchers from NYU Langone Medical Center.

31 Jan 2017

Scientists define working mechanism of promising anti-cancer molecules

An international team of scientists, including MIPT researchers, has defined the way their promising anti-cancer molecules work.

25 Jan 2017

BRCA1 gene required for survival of blood forming stem cells, UT Southwestern study finds

Researchers at from the Harold C. Simmons Comprehensive Cancer Center have found that the BRCA1 gene is required for the survival of blood forming stem cells, which could explain why patients with BRCA1 mutations do not have an elevated risk for leukemia.

25 Jan 2017

New biomarker helps better predict survival after surgical removal of colorectal metastases

Liver metastases are formed from cancer cells that have originated in other organs and migrated to the liver via the bloodstream. Colorectal cancer (cancer of the colon/rectum) can be successfully treated by surgical resection of the metastases in combination with chemotherapy.

23 Jan 2017

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Increase in BRCA testing may not necessarily mean better diagnosis of women at risk, study suggests

Study finds steady increase in BRCA testing among low-risk women

Researchers develop new method that uses gene editing to find cancer's weak spots

Studies question use of readmission rate as metric in surgeries for ovarian cancer patients

Researchers identify protein biomarker linked to prognosis in high-grade serous ovarian cancer

Clinical study seeks to examine new combination therapy for treating AML patients

Michigan Medicine opens first clinic in the United States that focuses on prostate cancer risk

Blocking protein found on surface of ovarian cancer cells could prevent metastasis, research suggests

NR could potentially prevent chemotherapy-induced peripheral neuropathy in cancer patients

Study: Hormonal maintenance therapy may improve survival in women with low-grade serous carcinoma

Early diagnosis does not necessarily result in longer life, study of cancer screenings shows

UT Southwestern scientists unravel role of PARP enzymes in major cellular activities

Analyzing copies of genes may offer new therapeutic approaches for ovarian cancer

Osmium-based compound seen to target cancer cells from inside

Study finds link between removal of ovaries and increased risk of heart disease, cancer and mortality

Yale researchers identify new genetic defect in brain tumor cells that prevents DNA repair

Defects in key gene spur breast and ovarian cancer growth, study shows

Scientists define working mechanism of promising anti-cancer molecules

BRCA1 gene required for survival of blood forming stem cells, UT Southwestern study finds

New biomarker helps better predict survival after surgical removal of colorectal metastases

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in